Financial comparisons Cybin Inc.

Equities

CLXPF

CA23256X4075

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 11:03:49 2025-06-16 am EDT 5-day change 1st Jan Change
8.070 USD -3.35% Intraday chart for Cybin Inc. -4.73% -8.73%
Main competitors
Revenues (Y-1) Net Margin (Y-1) EBIT Margin (Y-1) ROE (Y-1) ROA (Y-1) Leverage (Y-1)
- - - -45.91% - 2.66x
14.2B 31.07%36.33%19.23%15.02%-1.12x
2.22B 36.99%-0.96%2.26%2.02%234.49x
3.81B -16.92%-14.91%-18.77%-11%4.06x
5.38B 24.08%29.51%16.78%12.27%-0.97x
2.85B -24.18%-47.77%-3.3%-2.88%9.36x
364M -251.24%-241.47%-1,601.19%-54.47%0.16x
2.56B 17.97%25.37%11.65%8.43%-0.66x
2.99B 36.44%32.53%22.97%19.34%-2.97x
2.17B 24.04%27.88%23.13%17.7%-1.75x
291M -24.22%-26.28%-8.94%-4.69%-2.82x
265M -13.8%-7.18%-9.46%-9.11%3.86x
41.93M -410.18%-365.73% - - -
627M -28.22%-21.76%-15.45%-10.06%13.02x
180M -258.64%-276.39%-80.35% - 1.63x
297M 30.46%17.83%7.52%6.63%-9.98x
487M 40.03%45.91%30.74%24.08% -
Average 2.42B -49.15% -49.19% -103.07% 0.95% 16.60x
Weighted average by Cap. 4.62B -22.13% -25.06% -102.02% 1.24% 30.87x
Bio Therapeutic Drugs